G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 28.05 SEK 3.13% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Pre-Tax Income
kr23.2m
CAGR 3-Years
44%
CAGR 5-Years
35%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Pre-Tax Income
kr339m
CAGR 3-Years
-20%
CAGR 5-Years
16%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Pre-Tax Income
-kr1.7B
CAGR 3-Years
-214%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Pre-Tax Income
kr328m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
20%
MedCap AB (publ)
STO:MCAP
Pre-Tax Income
kr287.4m
CAGR 3-Years
41%
CAGR 5-Years
36%
CAGR 10-Years
33%
M
Magle Chemoswed Holding AB
STO:MAGLE
Pre-Tax Income
kr15.1m
CAGR 3-Years
85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Genovis AB
Glance View

Market Cap
1.8B SEK
Industry
Life Sciences Tools & Services

Genovis AB engages in the research and development of enzyme products. The company is headquartered in Lund, Skane. The company went IPO on 2005-11-11. The firm offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer, inflammatory and autoimmune diseases. The portfolio comprises FabRICATOR, a genetically modified enzyme the cleaves antibodies in two parts, and IgGZERO, a protein that specifically cleaves the sugar molecules that occur naturally on antibodies. The products within the nano portfolio are primarily directed at the preclinical market. The firm markets and sells its products through dealers and distributors in the European, North American and Asian continents. As of December 31, 2011, it operated a wholly owned subsidiary, Eijdo Research AB.

GENO Intrinsic Value
24.64 SEK
Overvaluation 12%
Intrinsic Value
Price
G

See Also

What is Genovis AB's Pre-Tax Income?
Pre-Tax Income
23.2m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Pre-Tax Income amounts to 23.2m SEK.

What is Genovis AB's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
35%

Over the last year, the Pre-Tax Income growth was -52%. The average annual Pre-Tax Income growth rates for Genovis AB have been 44% over the past three years , 35% over the past five years .

Back to Top